✦ LIBER ✦

186 Polychemotherapy with carboplatin (CBDA) and paclitaxel (TAX) in advanced NSCLC: A phase II study

✍ Scribed by von Bültzingslöwen, F.; Stoppert, C.; Weiß, J.; Matthiessen, W.; Syriste, T.; Vieweg, C.; Kettner, H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

171 Paclitaxel (TAX) and carboplatin (CB

✍ Deppermann, K.M.; Kurzeja, A.; Lichey, J.; Serke, M.; Riedel, U.; Loddenkemper, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 151 KB

A phase I–II study with carboplatin (C)

✍ Fabi, A.; Barduagni, M.; De Marco, S.; De Marinis, F.; Cortesi, E.; Foggi, C.M.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 330 KB

Paclitaxel (T) and carboplatin (C): A ph

✍ Fírvida, J.L; Amenedo, M; Salgado, M; Gonzalez-Quintas, A; Garcia Mata, J; Losad 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Phase II study of paclitaxel, ifosfamide

✍ Mauer, A.M; Ansari, R.H; Hoffman, P.C; Gabrys, T.G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 211 KB

A phase II study of combination paclitax

✍ W Yeo; T.W.T Leung; A.T.C Chan; S.K.W Chiu; P Yu; T.S.K Mok; P.J Johnson 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Phase II study of Topotecan (T) IV with

✍ Pujol, J.L; von Pawel, J; Tumolo, S; Martoni, A; Hearn, S; Fields, S.Z; Ross, G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 140 KB